Skip to content

Clinical trials

Phase 3 Anemia trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia Phase: Phase 3 Country / region: Austria Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20043
20051
20063
20072
20081
20091
20101
20111
20142
20163
20191
20201
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated3
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche6
Celgene3
Amgen2
Novartis Pharmaceuticals2
Sandoz2
Akebia Therapeutics1
Astellas Pharma Europe B.V.1
GlaxoSmithKline1
Medical University of Graz1
Pharmacosmos A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia24
Myelodysplastic Syndromes4
Renal Insufficiency, Chronic4
Primary Myelofibrosis3
Inflammatory Bowel Diseases2
Iron Deficiencies2
Myeloproliferative Disorders2
Renal Insufficiency2
Thalassemia2
Anemia, Diamond-Blackfan1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.